Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 15

1.

SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.

Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM, Lai R, Ritz J, Krause DS, Chai L.

Blood. 2006 Oct 15;108(8):2726-35. Epub 2006 Jun 8.

2.

Molecular bases of myelodysplastic syndromes: lessons from animal models.

Komeno Y, Kitaura J, Kitamura T.

J Cell Physiol. 2009 Jun;219(3):529-34. doi: 10.1002/jcp.21739. Review.

PMID:
19259975
3.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

4.

Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.

Harada Y, Harada H.

J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. Review.

PMID:
19334039
5.

Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.

Bernasconi P.

Br J Haematol. 2008 Sep;142(5):695-708. doi: 10.1111/j.1365-2141.2008.07245.x. Epub 2008 Jun 5. Review.

PMID:
18540941
6.

Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.

Liao R, Xu Y, Chen M, Chen X, Zhan X, Sun J.

Hematology. 2013 Jul;18(4):191-7. doi: 10.1179/1607845412Y.0000000053. Epub 2013 Jan 3. Review.

PMID:
23321417
7.

SALL4: an emerging cancer biomarker and target.

Zhang X, Yuan X, Zhu W, Qian H, Xu W.

Cancer Lett. 2015 Feb 1;357(1):55-62. doi: 10.1016/j.canlet.2014.11.037. Epub 2014 Nov 20. Review.

PMID:
25444934
8.

The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.

Karlic H, Herrmann H, Varga F, Thaler R, Reitermaier R, Spitzer S, Ghanim V, Blatt K, Sperr WR, Valent P, Pfeilstöcker M.

Crit Rev Oncol Hematol. 2014 Apr;90(1):1-16. doi: 10.1016/j.critrevonc.2013.10.003. Epub 2013 Oct 12. Review.

PMID:
24183913
9.

The role of stem cell factor SALL4 in leukemogenesis.

Gao C, Kong NR, Chai L.

Crit Rev Oncog. 2011;16(1-2):117-27. Review.

10.

Mouse models of myelodysplastic syndromes.

Beachy SH, Aplan PD.

Hematol Oncol Clin North Am. 2010 Apr;24(2):361-75. doi: 10.1016/j.hoc.2010.02.002. Review.

11.

How to establish acute myeloid leukemia xenograft models using immunodeficient mice.

Shan WL, Ma XL.

Asian Pac J Cancer Prev. 2013;14(12):7057-63. Review.

12.

DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.

Esposito MT, So CW.

Chromosoma. 2014 Dec;123(6):545-61. doi: 10.1007/s00412-014-0482-9. Epub 2014 Aug 12. Review.

PMID:
25112726
13.

How mRNA is misspliced in acute myelogenous leukemia (AML)?

Mohamed AM, Thénoz M, Solly F, Balsat M, Mortreux F, Wattel E.

Oncotarget. 2014 Oct 30;5(20):9534-45. Review.

14.

STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.

Bruserud Ø, Nepstad I, Hauge M, Hatfield KJ, Reikvam H.

Expert Rev Hematol. 2015 Feb;8(1):29-41. doi: 10.1586/17474086.2015.971005. Epub 2014 Nov 6. Review.

PMID:
25374305
15.

SALL4: engine of cell stemness.

Xiong J.

Curr Gene Ther. 2014;14(5):400-11. Review.

PMID:
25174577
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk